SEC Form 4 · open-market trades
Insider trading tracker
When a CEO, director or 10% owner buys or sells their own company's stock on the open market, they must file a Form 4 with the SEC within two business days. Every one of those trades filed since 2026-10-22 is here, updated hourly. Buys by several insiders at once (cluster buys) are the ones investors watch most.
Trades
531
Insider buys
145
Buy value
$33.69M
Cluster buys (30d)
8
Cluster buys — several insiders buying (last 30 days)
Rapport Therapeutics, Inc.
5 insiders · 6 buys · latest 2026-10-23
Sanchez Ramiro, Paul Steven M, Maraganore John, Young Wendy B.
CITY HOLDING CO
4 insiders · 4 buys · latest 2026-10-23
Fisher Robert D, Strong-Treister Diane W, Hoyer James A, Reyes Javier A
Rent the Runway, Inc.
3 insiders · 3 buys · latest 2026-10-23
Nexus Capital Management LP, STORY3 Capital Partners, LLC, CHS US Investments LLC
NXG NextGen Infrastructure Income Fund
2 insiders · 2 buys · latest 2026-10-23
Swank Jerry V, Nelson Blake
BNY MELLON STRATEGIC MUNICIPALS, INC.
2 insiders · 3 buys · latest 2026-10-22
Saba Capital Management, L.P., Bank Of America Corp /De/
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.
2 insiders · 3 buys · latest 2026-10-22
Saba Capital Management, L.P., Bank Of America Corp /De/
U S GLOBAL INVESTORS INC
2 insiders · 2 buys · latest 2026-10-22
Gator Capital Management, LLC, Pilecki Derek Steven
Nuveen Municipal Credit Opportunities Fund
2 insiders · 3 buys · latest 2026-10-22
Jones Nathaniel T., Bank Of America Corp /De/
Showing UTHR. Clear · Open UTHR analysis
| Filed | Ticker | Insider | Title | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,756 | $585.24 | $1.03M | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,280 | $586.31 | $750K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,200 | $584.21 | $701K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 937 | $587.24 | $550K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 783 | $588.19 | $461K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 760 | $583.09 | $443K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 400 | $581.83 | $233K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 360 | $581.03 | $209K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 280 | $577.28 | $162K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 240 | $589.50 | $141K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 190 | $576.80 | $110K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $590.40 | $94K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $579.69 | $93K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $578.59 | $93K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $571.76 | $91K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $570.08 | $91K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 160 | $565.09 | $90K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 130 | $575.32 | $75K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 110 | $563.98 | $62K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 74 | $562.97 | $42K | SEC filing |
| 2026-10-23 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 40 | $573.39 | $23K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,702 | $557.25 | $948K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,253 | $563.43 | $706K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 1,137 | $558.32 | $635K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 960 | $562.54 | $540K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 820 | $560.50 | $460K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 768 | $564.63 | $434K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 743 | $559.25 | $416K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 567 | $556.41 | $315K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 550 | $555.19 | $305K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 480 | $565.36 | $271K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 200 | $561.44 | $112K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 194 | $553.78 | $107K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 80 | $566.43 | $45K | SEC filing |
| 2026-10-22 | UTHR UNITED THERAPEUTICS Corp | Rothblatt Martine A | Chairperson & CEO | SELL | 46 | $552.52 | $25K | SEC filing |
Source: SEC EDGAR Form 4 filings (open-market purchases and sales only; option exercises, gifts and grants excluded). Research only, not investment advice.